1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A subcellular sampling instrument allows spatial resolution of amyloid deposit-derived organelle-specific effects in microglia

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Methodological developments in biomedical research are currently moving towards single-cell approaches. This allows for a much better spatial and functional characterization of, for example, the deterioration of cells within a tissue in response to noxae. However, subcellular resolution is also essential to elucidate whether observed impairments are driven by an explicit organelle. Here, we use the Single Cellome™ System SS2000 (Yokogawa) to investigate the local effects of Aβ plaque-like deposits (characteristic for Alzheimer’s disease) on mitochondria in the mouse microglial cell line SIM-A9. First, the specificity of subcellular extraction is demonstrated by detecting subcellular staining and RT-qPCR concerning marker genes by comparing nuclear and mitochondrial samples. Oxygen consumption and gene expression is then assessed in cells near and far from peptide deposits. Mostly, all analyses confirm the high specificity and integrity of the sampled material. In addition, impact of the peptide deposits occur concerning spatial distribution of the cells: e.g., oxygen consumption is only reduced in cells close to Aβ deposits but not in proximity to deposits of biologically inactive Aβ (scrambled) or in far distance. Moreover, a distance-related gene expression pattern occurs, demonstrating the local initiation of mitochondrial changes of microglia when approaching toxic peptide deposits.

          Abstract

          Aspiration of cellular content accompanied by confocal microscope-usage within the SS2000 allows investigation of organelle-enriched fractions and sheds light on selective effects of Aβ peptides.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.

          Alzheimer's disease (AD) is a detrimental neurodegenerative disease with no effective treatments. Due to cellular heterogeneity, defining the roles of immune cell subsets in AD onset and progression has been challenging. Using transcriptional single-cell sorting, we comprehensively map all immune populations in wild-type and AD-transgenic (Tg-AD) mouse brains. We describe a novel microglia type associated with neurodegenerative diseases (DAM) and identify markers, spatial localization, and pathways associated with these cells. Immunohistochemical staining of mice and human brain slices shows DAM with intracellular/phagocytic Aβ particles. Single-cell analysis of DAM in Tg-AD and triggering receptor expressed on myeloid cells 2 (Trem2)(-/-) Tg-AD reveals that the DAM program is activated in a two-step process. Activation is initiated in a Trem2-independent manner that involves downregulation of microglia checkpoints, followed by activation of a Trem2-dependent program. This unique microglia-type has the potential to restrict neurodegeneration, which may have important implications for future treatment of AD and other neurodegenerative diseases. VIDEO ABSTRACT.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease

              Reactive microglia are a major pathological feature of Alzheimer's disease (AD). However, the exact role of microglia in AD pathogenesis is still unclear. Here, using metabolic profiling, we found that exposure to amyloid-β triggers acute microglial inflammation accompanied by metabolic reprogramming from oxidative phosphorylation to glycolysis. It was dependent on the mTOR-HIF-1α pathway. However, once activated, microglia reached a chronic tolerant phase as a result of broad defects in energy metabolisms and subsequently diminished immune responses, including cytokine secretion and phagocytosis. Using genome-wide RNA sequencing and multiphoton microscopy techniques, we further identified metabolically defective microglia in 5XFAD mice, an AD mouse model. Finally, we showed that metabolic boosting with recombinant interferon-γ treatment reversed the defective glycolytic metabolism and inflammatory functions of microglia, thereby mitigating the AD pathology of 5XFAD mice. Collectively, metabolic reprogramming is crucial for microglial functions in AD, and modulating metabolism might be a new therapeutic strategy for AD.
                Bookmark

                Author and article information

                Contributors
                Kristina.endres@unimedizin-mainz.de
                Journal
                Commun Biol
                Commun Biol
                Communications Biology
                Nature Publishing Group UK (London )
                2399-3642
                3 January 2025
                3 January 2025
                2025
                : 8
                : 3
                Affiliations
                [1 ]Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, ( https://ror.org/00q1fsf04) Mainz, Germany
                [2 ]Institute of Molecular Biology, ( https://ror.org/05kxtq558) Mainz, Germany
                [3 ]Institute of Pharmacy, Johannes Gutenberg-University Mainz, ( https://ror.org/023b0x485) Mainz, Germany
                [4 ]Faculty of Computer Sciences and Microsystems Technology, Kaiserslautern University of Applied Sciences, ( https://ror.org/05dkqa017) Zweibrücken, Germany
                Author information
                http://orcid.org/0000-0001-8603-5957
                http://orcid.org/0000-0002-1099-8287
                Article
                7405
                10.1038/s42003-024-07405-w
                11699115
                39753747
                5c7c2e9e-3635-491b-a84a-d33c60d5f2d8
                © The Author(s) 2025

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 5 July 2024
                : 16 December 2024
                Funding
                Funded by: MWG Rheinland-Pfalz, Germany, SHARP projects and MultiSensE Yokogawa (Japan)
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2025

                diseases of the nervous system,neurological disorders

                Comments

                Comment on this article